3-(3,5-Dimethylisoxazol-4-yl)aniline

Catalog No. :
ACKZJE478
CAS No. :
875628-76-5
Molecular Formula :
C11H12N2O
Molecular Weight :
188.23

IUPAC Name:3-(3,5-dimethylisoxazol-4-yl)aniline

3-(3,5-Dimethylisoxazol-4-yl)aniline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$54.00Login to see priceIn stockInquiry
100mg98%$77.00Login to see priceIn stockInquiry
250mg98%$124.00Login to see priceIn stockInquiry
1g98%$332.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(3,5-Dimethylisoxazol-4-yl)aniline
IUPAC Name3-(3,5-dimethylisoxazol-4-yl)aniline
MDL No.MFCD20701923
Molecular FormulaC11H12N2O
Molecular Weight188.23
SMILESNC1=CC=CC(C2=C(C)ON=C2C)=C1
InChI KeyBYCNXHBVHHKZKE-UHFFFAOYSA-N
Synonym3-(3,5-Dimethyl-isoxazol-4-yl)-phenylamine;3-(3,5-Dimethylisoxazol-4-yl)aniline;Benzenamine, 3-(3,5-dimethyl-4-isoxazolyl)-
CAS No.875628-76-5
PubChem CID11687026

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACKZJE478 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHFGN659 route compound structure diagram
    ACHFGN65910557-85-4
  2. Plus
  3. ACKDRS250 route compound structure diagram
    ACKDRS25030418-59-8 In Stock
  4. Then
  5. ACKZJE478 route product structure diagram
    ACKZJE478875628-76-5 In Stock
Inquiry

2. ACKZJE478 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACROGU189 route compound structure diagram
    ACROGU18916114-47-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKZJE478 route product structure diagram
    ACKZJE478875628-76-5 In Stock
Inquiry

Comments (0)